Codes / ICD10CM / T45.1X1A

T45.1X1A Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter (ICD-10 code: T45.1X1A)

Summary

This condition describes accidental (unintentional) poisoning resulting from exposure to antineoplastic (cancer-fighting) and immunosuppressive drugs during the initial encounter. These medications, used to treat malignancies or manage immune responses, can cause toxic effects when administered incorrectly or inappropriately.

Causes

Accidental poisoning occurs due to unintended exposure to antineoplastic or immunosuppressive drugs. This may result from medication errors, improper handling, or accidental ingestion, inhalation, or contact with these substances. The toxicity arises from the drugs' effects on healthy cells or organ systems.

Risk Factors

  • Improper storage or handling of medications.
  • Lack of awareness about drug toxicity.
  • Accidental exposure in healthcare or home settings.
  • Pre-existing conditions affecting drug metabolism (e.g., renal or hepatic impairment).
  • Age-related vulnerability (e.g., pediatric or elderly populations).

Symptoms

Symptoms may include nausea, vomiting, diarrhea, fatigue, bone marrow suppression, organ dysfunction (e.g., liver or kidney), and increased infection risk. Severity depends on the drug type, dose, and exposure route.

Diagnosis

Diagnosis is based on a detailed history of exposure, clinical presentation, and laboratory tests (e.g., drug levels, organ function panels). Imaging or toxicology screens may be used to confirm the cause and extent of poisoning.

Treatment Options

Treatment focuses on stabilizing the patient, removing the toxin (e.g., decontamination), and managing symptoms. Supportive care (e.g., hydration, antiemetics) and specific antidotes (if available) may be administered. Consultation with a toxicologist or specialist is often recommended.

Prognosis and Follow-Up

Prognosis varies based on the drug, dose, and timely intervention. Early treatment improves outcomes. Follow-up includes monitoring for delayed effects, organ function, and potential long-term complications. Patient education on safe medication handling is critical.

Complications

Complications may include organ failure (e.g., renal, hepatic), severe infections, prolonged bone marrow suppression, or chronic toxicity. In severe cases, life-threatening reactions can occur.

Lifestyle & Prevention

Prevent accidental exposure by storing medications securely, using proper handling techniques, and following safety protocols. Educate patients and caregivers on drug risks and emergency procedures. Ensure clear labeling and disposal instructions.

When to Seek Professional Help

Seek immediate medical attention if accidental exposure is suspected, especially with symptoms like severe nausea, vomiting, dizziness, or altered consciousness. Prompt evaluation is essential to minimize harm.

Tips for Medical Coders

Document the accidental (unintentional) nature of the poisoning and confirm it is the initial encounter. Include details on the specific antineoplastic or immunosuppressive drug involved, exposure route, and clinical findings to support coding accuracy.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T45.1X1A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.